These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...

India's one-shot dengue vaccine 'DengiAll' reaches 70% enrolment in Phase III trials across 20 national sites.

Daniel Cressy will be the first patient in Louisiana to complete the gene therapy treatment for sickle cell disease.

Guidance for Q3 2025 adjusted EPS of $1.53–$1.61 is slightly lower than the Q2 actual, reflecting anticipated legal costs. Strategic focus shifted toward the integration of Mod3 Pharma, increased ...

Lee Jacobs, co-founder of Long Journey Ventures, thought he had seen it all among his friends and acquaintances in Silicon ...

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

Q2 2025 Earnings Call Transcript July 31, 2025 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, ...

India achieves a milestone in dengue prevention. The DengiAll vaccine trial sees 70% participant enrollment. ICMR leads the ...

New Jersey’s secure treatment center for detaining sex offenders is supposed to keep the public safe. Critics say it violates ...

To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test ...

President Donald Trump and members of his administration announced the AI-focused "Make Health Tech Great Again" initiative ...